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Abstract
Background: Phenylketonuria is an inborn error of amino acid metabolism which can cause
severe damage to the patient or, in the case of maternal phenylketonuria, to the foetus. The
maternal phenylketonuria syndrome is caused by high blood phenylalanine concentrations during
pregnancy and presents with serious foetal anomalies, especially congenital heart disease,
microcephaly and mental retardation.
Case presentation: We report on an affected Albanian woman and her seven children. The
mother is affected by phenylketonuria and is a compound heterozygote for two pathogenetic
mutations, L48S and P281L. The diagnosis was only made in the context of her children, all of whom
have at least one severe organic malformation. The first child, 17 years old, has a double-chambered
right ventricle, vertebral malformations and epilepsy. She is also mentally retarded, microcephalic,
exhibits facial dysmorphies and small stature. The second child, a girl 15 years of age, has severe
mental retardation with microcephaly, small stature and various dysmorphic features. The next
sibling, a boy, died of tetralogy of Fallot at the age of three months. He also had multiple vertebral
and rib malformations. The subsequent girl, now eleven years old, has mental retardation,
microcephaly and epilepsy along with facial dysmorphy, partial deafness and short stature. The
eight-year-old child is slightly mentally retarded and microcephalic. A five-year-old boy was a
premature, dystrophic baby and exhibits mental retardation, dysmorphic facial features,
brachydactyly and clinodactyly of the fifth finger on both hands. Following a miscarriage, our index
case, the youngest child at two years of age, is microcephalic and mentally retarded and shows
minor facial anomalies. All children exhibit features of phenylalanine embryopathy caused by
maternal phenylketonuria because the mother had not been diagnosed earlier and, therefore, never
received any diet.
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Conclusion: This is the largest family suffering from maternal phenylketonuria reported in the
literature. Maternal phenylketonuria remains a challenge, especially in woman from countries
without a neonatal screening program. Therefore, it is mandatory to be alert for the possibility of
maternal phenylketonuria syndrome in case of a child with the clinical features described here to
prevent foetal damage in subsequent siblings.
Background
Phenylketonuria (PKU; OMIM *261600) is an autosomal
recessive disorder of phe metabolism which can cause
severe damage to the patient or, in the case of maternal
PKU, to the offspring. The teratogenic effects of elevated
maternal phe levels was first recognised in the mid nine-
teen sixties, at a time when routine newborn screening
and diet treatment of PKU was being established in most
developed countries [Mabry et al., 1966]. Typical features
in offspring with phe embryopathy include microcephaly,
mental retardation and heart malformation. The severity
of maternal PKU syndrome is proportional to maternal
blood phe concentrations, and a strict dietary control
prior to conception and throughout pregnancy is manda-
tory to prevent congenital foetal anomalies [Rouse et al.,
2000].
With our case report on an exceptional Albanian family,
we wish to highlight the problem of untreated or undiag-
nosed PKU in adult women, resulting in the risk of severe
maternal PKU syndrome in children.
Case presentation
Our index case, a 2-year-old girl, is the 7th living child
born to her mother (Figure 1). She was admitted to our
hospital for further diagnostic work-up. Her birth weight
was below 2500 g, as was the case for all her siblings.
Additionally, she showed microcephaly, mental retarda-
tion and facial anomalies (long underdeveloped
philtrum, high palate, anteverted nostrils). She also exhib-
ited a large diastase of the abdominal rectus muscle.
Case 1, the oldest child of the non-consanguine family, a
17-year-old girl, has a double-chambered right ventricle,
multiple vertebral malformations of the thoracic and lum-
bal spine and epileptic seizures. She also shows severe
mental retardation, microcephaly, facial dysmorphology
(long underdeveloped philtrum, broad nasal bridge,
micrognathism, high palate, divergent strabism) and
stunted growth.
Case 2, the 15 year-old sister, presented with severe men-
tal retardation, microcephaly, facial dysmorphology (long
underdeveloped philtrum, micrognathism, high palate,
divergent strabism) and stunted growth. In addition, he
has brachydactyly and clinodactyly of the fifth fingers of
both hands.
Case 3, a dystrophic boy, died at the age of 3 months of
Fallot's tetralogy. He also had vertebral malformations
such as hemivertebrae, rib fusions and thoracic scoliosis
(Figure 2).
Case 4, an 11-year-old girl, presented with microcephaly
and facial dysmorphology (long underdeveloped
philtrum, broad nasal bridge, micrognathism, dysplastic
ear helices, strabism), partial deafness, mental retarda-
tion, absence epilepsy and stunted growth.
Case 5, an 8-year-old girl, was slightly mentally retarded
and microcephalic, with minor facial anomalies and short
stature.
Portrait of the index patient Figure 1
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Case 6, a 5-year-old boy, was a preterm baby and small for
gestational age. He also presented with microcephaly,
facial dysmorphology and micrognathism. Brachydactyly
and clinodactyly of the fifth fingers of both hands were
noted.
The mother had one miscarriage between her 6th child and
our index patient, case 7. The stillbirth occurred in the 7th
month of pregnancy.
Further diagnostic work-up in case 1 to 7 was unremarka-
ble. Because of the characteristic features of all her chil-
dren, maternal serum phe concentration was analysed.
The blood phe level was greatly elevated with 1560 µmol/
L (normal < 90 µmol/L). Urinary organic acid analysis
showed high excretion of phenylpyruvic, phenylacetic,
hydroxyphenylacetic and phenyllactic acids as well as
mandelic acid. Mutation analysis revealed that the mother
was compound hetereozygous for the mutations L48S
and P281L in the PAH gene. This disease was previously
unknown to the mother. A newborn screening program
had not yet been established in 1963 in Albania when the
mother was born. The mother did not wish to maintain a
phe-restrictive or protein-restrictive diet, and the children
were unavailable to us for a long-term follow-up.
Conclusion
The case histories of the patients reported here provide
further information on the maternal PKU syndrome,
which causes heart malformation, microcephaly, mental
retardation and stunted growth, respectively [Koch et al.,
2003;Lee et al., 2003;Levy et al., 2001;Rouse et al., 1997],
since it is the largest family suffering from maternal PKU
reported in the literature. There are several reports of undi-
agnosed maternal PKU in the English language literature
[Starostecka et al., 2001;Hanley et al., 1999], however,
none with as many as 7 offspring. The disease was previ-
ously unknown to the mother who had visited a primary
school and was not noted to have subnormal intelligence.
The mother did not speak German but was socially inte-
grated. Interestingly, the couple reported restricted food,
especially of protein-rich meals, in Albania due to their
low social status. However, seven of the children were
born in Germany. All offspring had normal phe serum
concentrations. The genotype identified in the mother of
our patients, compound heterozygosity for the common
mutations L48S and P281L, is associated with complete
loss of enzyme activity of PAH and a classical PKU pheno-
type [Zschocke, 2003]. Since untreated PKU does not, in
all patients, lead to severe neurological symptoms and
profound mental handicap, as in the mother described
here, there is a continuing need to be alert for the possibil-
ity of maternal PKU syndrome to prevent phe embryopa-
thy in subsequent siblings. Although the condition is well
known, it remains a problem, particularly in women born
in countries without neonatal screening programs. How-
ever, the incidence of undiagnosed maternal PKU is cur-
rently estimated at 1 case per 100,000 births or even
higher in Europe and the US [Hanley et al., 1999].
In conclusion, maternal blood phe concentrations should
be investigated in the case of an otherwise unexplained
neonatal syndrome presenting with microcephaly, facial
dysmorphy and heart malformation, particularly in moth-
ers born in countries without neonatal screening pro-
grams even if there is no obvious maternal mental
retardation. Our case report clearly demonstrates that
maternal PKU is still a challenge to be faced.
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Chest x-ray of case 3 who died of Fallot's tetralogy Figure 2
Chest x-ray of case 3 who died of Fallot's tetralogy. The pic-
ture exhibits vertebral and rib malformations and fusions 
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